Renal tubular toxicity of HMG-CoA reductase inhibitors

被引：25

作者：

van Zyl-Smit, R

Firth, JC

Duffield, M

Marais, AD

机构：

[1] Univ Cape Town, Groote Schuur Hosp Observ, Dept Med, ZA-7935 Cape Town, South Africa

[2] Univ Cape Town, Dept Pathol, ZA-7925 Cape Town, South Africa

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2004年 / 19卷 / 12期

关键词：

HMG-CoA reductase inhibitor; hypercholesterolaemia; nephrotoxicity; proteinuria; statin;

D O I：

10.1093/ndt/gfh474

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：3176 / 3179

页数：4

共 5 条

[1] EXOGENOUS COQ(10) SUPPLEMENTATION PREVENTS PLASMA UBIQUINONE REDUCTION INDUCED BY HMG-COA REDUCTASE INHIBITORS [J].

BARGOSSI, AM ;

GROSSI, G ;

FIORELLA, PL ;

GADDI, A ;

DIGIULIO, R ;

BATTINO, M .

MOLECULAR ASPECTS OF MEDICINE, 1994, 15 :187-193

[2] Statins and risk of polyneuropathy -: A case-control study [J].

Gaist, D ;

Jeppesen, U ;

Andersen, M ;

Rodríguez, LAG ;

Hallas, J ;

Sindrup, SH .

NEUROLOGY, 2002, 58 (09) :1333-1337

[3] Oxidation injury in patients receiving HMG-CoA reductase inhibitors - Occurrence in patients without enzyme elevation or myopathy [J].

Sinzinger, H ;

Chehne, F ;

Lupattelli, G .

DRUG SAFETY, 2002, 25 (12) :877-883

[4] HMG-CoA reductase inhibitors and myotoxicity [J].

Ucar, M ;

Mjörndal, T ;

Dahlqvist, R .

DRUG SAFETY, 2000, 22 (06) :441-457

[5]

VOGEL RA, 1997, CLIN CARDIOL, V54, P311

← 1 →